Kristie Ann Wagner - 24 Feb 2022 Form 3 Insider Report for Entasis Therapeutics Holdings Inc.

Role
VP, Principal Fin & Acct Off
Signature
/s/ Elizabeth M. Keiley as Attorney-in-Fact for Kristie Wagner
Issuer symbol
N/A
Transactions as of
24 Feb 2022
Net transactions value
$0
Form type
3
Filing time
25 Feb 2022, 15:30:06 UTC
Next filing
11 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ETTX Common Stock 70,500 24 Feb 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ETTX Employee Stock Option (Right to Buy) 24 Feb 2022 Common Stock 73,400 $2.40 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit award granted on January 18, 2022. The award vests over four years with twenty-five percent (25%) of the award vesting on each anniversary of the date of grant, subject to the reporting person's continued employment with the Company through each such date.
F2 Twenty-five percent (25%) of the shares subject to the option shall vest on June 7, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person's continued employment with the Company through each such date.

Remarks:

See Exhibit 24 - Power of Attorney